Michael Raab's Net Worth

$10.8 Million

Estimate Recalculated Nov 11, 2024 01:01PM EST

Who is Michael Raab

Michael Raab has an estimated net worth of $10.8 Million. This is based on reported shares across multiple companies, which include AMICUS THERAPEUTICS, INC., Tempest Therapeutics, Inc., ARDELYX, INC., NOVACEA INC, and INTARCIA THERAPEUTICS, INC.

SEC CIK

Michael Raab's CIK is 0001321402

Past Insider Trading and Trends

2021 was Michael Raab's most active year for acquiring shares with 11 total transactions. Michael Raab's most active month to acquire stocks was the month of May. 2024 was Michael Raab's most active year for disposing of shares, totalling 18 transactions. Michael Raab's most active month to dispose stocks was the month of May. 2021 saw Michael Raab paying a total of $187,254.72 for 1,290,722 shares, this is the most they've acquired in one year. In 2020 Michael Raab cashed out on 188,583 shares for a total of $920,333.73, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AMICUS THERAPEUTICS, INC.

Investor
Updated Jun 07, 2024
Form 4
64.97%
54.31K
Jun 07, 2024
137.91K
Grant
Jun 06
Form 4
$2.80
$42.00K
Mar 06, 2024
83.60K
Options
Mar 05
Form 4
65.08%
39.06K
Jun 12, 2023
99.07K
Grant
Jun 08
Form 4
-6.84%
-4.41K
$7.33
-$142.64
Mar 21, 2023
60.01K
Sale
Mar 17
Form 4
158.08%
58.09K
Jun 10, 2022
94.84K
Grant
Jun 09
Form 4
-28.99%
-15.00K
$5.89
-$33.04K
May 04, 2022
36.75K
Sale
ScheduledMay 02
Form 4
173.56%
46.23K
Jun 14, 2021
72.86K
Grant
Jun 10
Form 4
$7.56
$42.59K
May 20, 2021
26.63K
Options
May 18
Form 4
161.30%
24.43K
Jun 08, 2020
39.57K
Grant
Jun 04
Form 4
-24.82%
-5.00K
$7.73
-$49.21K
Jun 03, 2020
15.15K
Sale
ScheduledJun 01
Form 4
289.18%
25.72K
Jul 01, 2019
34.62K
Grant
Jun 27
Form 4
-35.98%
-5.00K
$9.16
-$20.03K
Jun 04, 2019
8.90K
Sale
ScheduledJun 03
Form 4
206.28%
11.99K
Jun 11, 2018
17.81K
Grant
Jun 07
Form 4
-46.24%
-5.00K
$12.47
-$19.41K
Apr 18, 2018
5.81K
Sale
ScheduledApr 16
Form 4
-36.28%
-9.37K
$15.00
Jan 04, 2018
16.45K
Sale
ScheduledJan 02
Form 4
-38.74%
-10.00K
$14.25
Oct 16, 2017
15.81K
Sale
ScheduledOct 12
Form 4
22.05K
Jun 15, 2017
22.05K
Grant
Jun 13
Form 4
20.00K
Jun 13, 2016
20.00K
Grant
Jun 09
Form 4
20.00K
Jun 12, 2015
20.00K
Grant
Jun 10
Form 4
-100.00%
-8.94K
$12.65
-$113.04K
Jun 09, 2015
Disposition
ScheduledJun 08
Form 4
15.00K
Jun 16, 2014
15.00K
Grant
Jun 12
Form 4
15.00K
Jun 17, 2013
15.00K
Grant
Jun 13
Form 4
15.00K
Jun 15, 2012
15.00K
Grant
Jun 13
Form 4
10.00K
Jun 14, 2011
10.00K
Grant
May 24
Form 4
10.00K
Jun 16, 2010
10.00K
Grant
Jun 15
Form 4
10.00K
Jun 11, 2009
10.00K
Grant
Jun 10
Form 4
10.00K
Jun 11, 2008
10.00K
Grant
Jun 10
Form 3
May 30, 2007
Showing 28 results

Tempest Therapeutics, Inc.

Investor
Updated Jun 14, 2024
Form 4
16.00K
Jun 14, 2024
16.00K
Grant
Jun 13
Form 4
8.20K
Jun 20, 2023
8.20K
Grant
Jun 15
Form 4
3.50K
Jun 22, 2022
3.50K
Grant
Jun 17
Form 4
6.63K
Sep 23, 2021
6.64K
Grant
Sep 21
Form 4
31.27K
Jun 29, 2021
31.27K
Grant
Jun 25
Form 3
Jun 29, 2021
Showing 6 results

ARDELYX, INC.

President & CEO
Updated Oct 31, 2024
Form 4
-1.40%
-25.00K
$3.45
-$122.99K
Oct 31, 2024
1.78M
Sale
ScheduledOct 28
Form 4
-0.62%
-7.50K
$6.01
-$45.07K
Oct 15, 2024
1.24M
Sale
ScheduledOct 11
Form 4
-1.92%
-35.00K
$3.30
-$161.75K
Sep 13, 2024
1.82M
Sale
Sep 11
Form 4
-0.61%
-7.50K
$6.22
-$46.63K
Aug 28, 2024
1.24M
Sale
ScheduledAug 27
Form 4
-2.56%
-32.23K
$5.86
-$188.85K
Aug 22, 2024
1.25M
Sale
Aug 20
Form 4
-0.10%
-1.23K
$5.71
-$7.02K
Aug 14, 2024
1.28M
Sale
ScheduledAug 12
Form 4
-1.58%
-30.00K
$3.32
-$139.61K
Jul 31, 2024
1.89M
Sale
ScheduledJul 29
Form 4
-0.59%
-7.50K
$5.97
-$44.77K
Jul 17, 2024
1.29M
Sale
ScheduledJul 15
Form 4
-0.18%
-2.31K
$6.59
-$15.22K
Jun 28, 2024
1.29M
Sale
ScheduledJun 28
Form 4
-1.78%
-35.00K
$3.82
-$198.09K
Jun 17, 2024
1.96M
Sale
ScheduledJun 13
Form 4
-0.59%
-7.50K
$6.72
-$50.39K
May 31, 2024
1.30M
Sale
ScheduledMay 29
Form 4
-2.40%
-31.48K
$7.81
-$245.92K
May 23, 2024
1.30M
Sale
May 21
Form 4
-0.23%
-3.00K
$7.99
-$23.97K
May 15, 2024
1.33M
Sale
May 14
Form 4
-1.49%
-30.00K
$3.70
-$162.36K
May 01, 2024
2.01M
Sale
Apr 29
Form 4
-0.57%
-7.50K
$7.06
-$52.92K
Apr 17, 2024
1.34M
Sale
Apr 15
Form 4
-0.12%
-1.52K
$7.31
-$11.10K
Apr 02, 2024
1.34M
Sale
Apr 01
Form 4
-1.71%
-22.92K
$8.75
-$200.44K
Feb 22, 2024
1.35M
Sale
Feb 20
Form 4
124.55%
1.08M
Jan 18, 2024
1.97M
Grant
Jan 16
Form 4
-1.29%
-11.37K
$4.36
-$49.59K
Nov 22, 2023
893.23K
Sale
Nov 20
Form 4
-1.29%
-11.42K
$3.55
-$40.56K
Aug 23, 2023
901.60K
Sale
Aug 21
Form 4
-1.26%
-11.36K
$3.65
-$41.49K
May 25, 2023
913.02K
Sale
May 23
Form 4
-1.48%
-13.45K
$3.00
-$40.36K
Feb 24, 2023
921.38K
Sale
Feb 21
Form 4
208.35%
1.37M
Jan 06, 2023
2.06M
Grant
Jan 05
Form 4
-0.93%
-6.22K
$1.95
-$12.12K
Nov 23, 2022
684.83K
Sale
Nov 22
Form 4
0.45%
3.00K
$0.62
$1.86K
Sep 01, 2022
691.04K
Purchase
Aug 31
Form 4
-0.92%
-6.15K
$0.98
-$6.05K
Aug 24, 2022
688.04K
Sale
Aug 22
Form 4
-13.41%
-103.62K
$0.65
-$67.42K
Jun 08, 2022
694.19K
Sale
Jun 06
Form 4
-0.79%
-6.12K
$0.67
-$4.11K
May 23, 2022
797.81K
Sale
May 20
Form 4
-0.80%
-6.23K
$0.67
-$4.17K
Feb 25, 2022
800.94K
Sale
Feb 22
Form 4
134.54%
850.00K
Jan 12, 2022
1.51M
Grant
Jan 06
Form 4
-0.41%
-2.61K
$0.99
-$2.59K
Nov 24, 2021
657.17K
Sale
Nov 22
Form 4
89.71%
300.00K
Oct 29, 2021
659.77K
Grant
Oct 08
Form 4
-0.77%
-2.57K
$1.32
-$3.40K
Aug 24, 2021
355.09K
Sale
Aug 20
Form 4
-31.15%
-150.34K
$1.09
-$101.90K
Aug 05, 2021
357.67K
Options
Aug 03
Form 4
-1.17%
-2.53K
$7.09
-$17.96K
May 21, 2021
240.12K
Sale
May 20
Form 4
-1.15%
-2.53K
$6.88
-$17.44K
Feb 24, 2021
242.65K
Sale
Feb 22
Form 4
604.53%
633.06K
Jan 07, 2021
763.15K
Grant
Jan 05
Form 4
-50.38%
-106.34K
$5.61
-$596.28K
Sep 17, 2020
130.08K
Sale
Sep 15
Form 4
-48.70%
-23.13K
$7.01
-$162.13K
Jul 06, 2020
233.42K
Sale
ScheduledJul 02
Form 4
2.67%
1.24K
Jun 12, 2020
256.55K
Acquisition
Jun 10
Form 4
-33.33%
-23.13K
$7.33
-$169.63K
Jun 02, 2020
255.31K
Sale
ScheduledJun 01
Form 4
-22.74%
-20.43K
$7.01
-$143.22K
May 05, 2020
278.44K
Sale
ScheduledMay 04 - May 05
Form 4
-18.53%
-20.43K
$7.02
-$143.33K
Apr 17, 2020
298.87K
Sale
ScheduledApr 15 - Apr 17
Form 4
-9.02%
-31.55K
$4.05
-$209.13K
Mar 04, 2020
319.30K
Sale
ScheduledMar 02
Form 4
-10.29%
-25.00K
$4.20
-$155.93K
Feb 07, 2020
349.62K
Sale
ScheduledFeb 05
Form 4
557.46K
Jan 13, 2020
557.46K
Grant
Jan 09
Form 4
-3.80%
-10.05K
$2.54
-$25.55K
Jun 06, 2019
336.19K
Sale
Jun 04
Form 4
455.00K
Jan 22, 2019
455.00K
Grant
Jan 17
Form 4
-6.99%
-19.64K
$1.70
-$33.42K
Jan 04, 2019
343.24K
Sale
Jan 02
Form 4
-2.19%
-6.54K
$2.84
-$18.57K
Nov 15, 2018
362.88K
Sale
Nov 13
Form 4
388.74%
385.00K
Jul 30, 2018
554.42K
Grant
Jul 26
Form 4
390.35K
Jan 18, 2018
390.35K
Grant
Jan 16
Form 4
815.62%
159.07K
Aug 11, 2017
248.96K
Grant
Aug 07 - Aug 09
Form 4
22,142.69%
336.13K
Jan 23, 2017
408.03K
Grant
Jan 19
Form 4
301.26K
Jan 20, 2016
301.26K
Grant
Jan 15
Form 4
-12.21%
-9.79K
$20.29
-$198.54K
Sep 10, 2015
71.90K
Sale
ScheduledSep 08
Form 4
-1.36%
-1.10K
$20.00
-$22.08K
Aug 27, 2015
80.17K
Sale
ScheduledAug 18
Form 4
-0.37%
-300.00
$20.00
-$6.00K
Aug 04, 2015
81.27K
Sale
ScheduledAug 03
Form 4
-2.52%
-2.11K
$20.00
-$42.22K
Jul 30, 2015
81.57K
Sale
ScheduledJul 28
Form 4
27.00
Mar 12, 2015
83.69K
Acq/Dis
Dec 23
Form 4
75.00K
Jan 08, 2015
75.00K
Grant
Jan 06
Form 3
Jun 18, 2014
83.66K
Showing 62 results

NOVACEA INC

Investor
Updated Feb 02, 2009
Form 4
Feb 02, 2009
Form 4/A
20.00K
Mar 31, 2008
20.00K
Grant
Feb 13
Form 4
12.50K
Feb 19, 2008
12.50K
Grant
Feb 13
Form 4
12.50K
Jan 19, 2007
12.50K
Grant
Jan 17
Form 3
May 09, 2006
Showing 5 results

INTARCIA THERAPEUTICS, INC

Investor
Updated Sep 20, 2005
Form 3
Sep 20, 2005
Showing 1 results